(INS) Lyxor - Lyxor STOXX Europe - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: FR0010344903

Financial, Services, Insurance, Shares, ETF

Description: INS Lyxor - Lyxor STOXX Europe

The Lyxor STOXX Europe 600 Insurance UCITS ETF is an exchange-traded fund that tracks the performance of insurance companies listed in Europe, providing investors with exposure to the European insurance sector. As a Sector Equity Financial Services ETF, it is designed to give investors a targeted investment in this specific area of the financial services industry.

The funds underlying index is related to the Morningstar Global Financial Services sector, indicating its focus on financial services companies, although it specifically tracks the STOXX Europe 600 Insurance index. This suggests a concentrated investment in insurance companies within the broader European financial services landscape.

From a technical analysis perspective, the ETFs price action indicates a bullish trend, with the short-term and long-term moving averages (SMA20, SMA50, SMA200) all pointing upwards, suggesting a sustained increase in value. The Average True Range (ATR) of 1.62, or 1.95%, indicates moderate volatility, which is relatively contained and may appeal to investors seeking to manage risk. Given the current price is near its 52-week high, and considering the upward trend indicated by the moving averages, a potential forecast could be that the ETF continues to rise, potentially testing new highs.

Combining technical and fundamental analysis, with the Assets Under Management (AUM) standing at 60.39M EUR, the fund has a solid base of investor support. The upward trend in the ETFs price, coupled with its focus on the European insurance sector, suggests that investors are optimistic about the sectors prospects. If the European insurance sector continues to grow or stabilize, this could bode well for the ETFs future performance.

Forecasting future performance based on both technical and fundamental data, if the trend continues and the sector remains favorable, the Lyxor STOXX Europe 600 Insurance UCITS ETF could potentially reach new highs, possibly exceeding its current 52-week high of 83.37. However, its crucial to monitor both the technical indicators for signs of reversal and fundamental changes in the insurance sector that could impact the ETFs performance.

Additional Sources for INS ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

INS ETF Overview

Market Cap in USD 71m
Category Sector Equity Financial Services
TER 0.30%
IPO / Inception 2016-12-13

INS ETF Ratings

Growth Rating 91.4
Fundamental -
Dividend Rating 4.82
Rel. Strength -0.3
Analysts -
Fair Price Momentum 86.51 EUR
Fair Price DCF -

INS Dividends

Currently no dividends paid

INS Growth Ratios

Growth Correlation 3m 35.2%
Growth Correlation 12m 96.3%
Growth Correlation 5y 95.9%
CAGR 5y 17.28%
CAGR/Max DD 5y 0.94
Sharpe Ratio 12m 2.55
Alpha 19.69
Beta 0.418
Volatility 13.82%
Current Volume 0.6k
Average Volume 20d 1.1k
What is the price of INS shares?
As of July 07, 2025, the stock is trading at EUR 80.95 with a total of 581 shares traded.
Over the past week, the price has changed by +0.07%, over one month by -3.26%, over three months by +15.96% and over the past year by +29.93%.
Is Lyxor - Lyxor STOXX Europe a good stock to buy?
Yes. Based on ValueRay's Analyses, Lyxor - Lyxor STOXX Europe (PA:INS) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 91.41 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of INS is around 86.51 EUR . This means that INS is currently overvalued and has a potential downside of 6.87%.
Is INS a buy, sell or hold?
Lyxor - Lyxor STOXX Europe has no consensus analysts rating.
What are the forecasts for INS share price target?
According to our own proprietary Forecast Model, INS Lyxor - Lyxor STOXX Europe will be worth about 96.4 in July 2026. The stock is currently trading at 80.95. This means that the stock has a potential upside of +19.1%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 96.4 19.1%